Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Class A Ordinary Shares, $0.0001 par value per share
-
Shares outstanding
-
15,139,982,333
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
821,611
-
Shares change
-
-1,790,656
-
Total reported value, excl. options
-
$468,070
-
Value change
-
-$1,586,794
-
Number of buys
-
8
-
Number of sells
-
-12
-
Price
-
$0.5700
Significant Holders of TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) as of Q1 2025
32 filings reported holding TRIB - TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share as of Q1 2025.
TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 821,611 shares
of 15,139,982,333 outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (375,110 shares), Whitefort Capital Management, LP (81,902 shares), RENAISSANCE TECHNOLOGIES LLC (76,665 shares), HRT FINANCIAL LP (66,242 shares), CITADEL ADVISORS LLC (41,539 shares), Moss Adams Wealth Advisors LLC (25,666 shares), RAYMOND JAMES FINANCIAL INC (25,362 shares), Cambridge Investment Research Advisors, Inc. (22,280 shares), Williams & Novak, LLC (18,200 shares), and BECKER CAPITAL MANAGEMENT INC (18,000 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.